Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Clin Oncol (R Coll Radiol) ; 36(1): 30-38, 2024 01.
Article in English | MEDLINE | ID: mdl-37827946

ABSTRACT

AIM: To compare the clinical efficacy and safety of first-line treatments for advanced unresectable oesophageal squamous cell cancer. MATERIALS AND METHODS: A systematic review and network meta-analysis was carried out by retrieving and retaining relevant literature from databases. The studies were randomised controlled trials comparing first-line treatments for advanced unresectable oesophageal squamous cell cancer. A Bayesian network meta-analysis was used to assess clinical outcomes. RESULTS: Nine studies including 4499 patients receiving first-line treatments were analysed. For all populations, toripalimab plus chemotherapy tended to provide the best overall survival (hazard ratio 0.58, 95% confidence intervals 0.43-0.78) and sintilimab plus chemotherapy provided the best progression-free survival (0.56, 0.46-0.68). Nivolumab plus chemotherapy presented the best objective response rate (odds ratio 2.45, 1.78-3.42) and camrelizumab plus chemotherapy (0.47, 0.29-0.74) appeared to be the safest. Sintilimab plus chemotherapy (0.55, 0.40-0.75) and nivolumab (0.54, 0.37-0.80) plus chemotherapy had the best overall survival in programmed death ligand 1 (PD-L1) tumour proportion score <1% and ≥1% subgroups. Toripalimab plus chemotherapy (0.61, 0.40-0.93) and pembrolizumab (0.57, 0.43-0.75) were the best in overall survival in combined positive score <10 and ≥10 subgroups, respectively. Toripalimab plus chemotherapy showed the best overall survival in the Asian group; pembrolizumab presented better overall survival in the Asian population than the non-Asian group. CONCLUSION: Most immunotherapy combined with chemotherapy showed superior clinical benefits and sintilimab plus chemotherapy, toripalimab plus chemotherapy and tislelizumab plus chemotherapy had better comprehensive clinical efficacy. PD-L1 expression detection and ethnicity differences are still of great significance and most suitable regimens varied from each subgroup.


Subject(s)
Esophageal Neoplasms , Esophageal Squamous Cell Carcinoma , Lung Neoplasms , Humans , Nivolumab/therapeutic use , B7-H1 Antigen , Network Meta-Analysis , Bayes Theorem , Esophageal Squamous Cell Carcinoma/drug therapy , Esophageal Neoplasms/pathology , Epithelial Cells/pathology , Antineoplastic Combined Chemotherapy Protocols/adverse effects
2.
Article in English | MEDLINE | ID: mdl-12041551

ABSTRACT

Paragonimiasis in Yongjia County, Zhejiang Province, China, has been of such public health concern that a specialized Institute for Paragonimiasis Control has been established there. The study reported here involved both parasitological research on Paragonimus westermani in the endemic areas and a clinical analysis of 94 cases of paragonimiasis. Eggs were found in sputum, feces and brain tissue in 45 cases. Twenty patients, 19 of whom where children under 10 years of age, showed hepatic injury. Treatment with praziquantel or bithionol had satisfactory results in all cases. Dimensions of the parasite eggs, metacercariae from freshwater crabs and adult flukes suggested that the form of P. westermani in Yongjia is the 'small type': a suggestion supported by karyotypic studies on gonad cells from adult flukes collected from experimentally infected animals as all were found to be diploid. In conclusion, the 'small type' or diploid form of P. westermani is the cause of paragonimiasis pulmonary symptoms in Yongjia.


Subject(s)
Paragonimiasis , Adolescent , Adult , Animals , Antiplatyhelmintic Agents/therapeutic use , Bithionol/therapeutic use , Carnivora , Cats , Child , China/epidemiology , Dogs , Endemic Diseases , Enzyme-Linked Immunosorbent Assay , Female , Humans , Karyotyping , Male , Microscopy, Electron, Scanning , Middle Aged , Paragonimiasis/drug therapy , Paragonimiasis/genetics , Paragonimiasis/parasitology , Paragonimiasis/pathology , Paragonimus/genetics , Paragonimus/isolation & purification , Parasite Egg Count
3.
Acupunct Electrother Res ; 26(3): 165-70, 2001.
Article in English | MEDLINE | ID: mdl-11761445

ABSTRACT

The hypertensive rat model was made by chronic stress of electric foot-shocks and noises. On such hypertensive rats, when anesthetized with urethane and chloralose, the electroacupuncture (EA) to bilateral "Zusanli (st.36)" acupoints for 20 min, could result in a depressor (including both systolic and diastolic pressure) and bradycardiac response as well as an attenuation in the maximum of left ventricular pressure, end diastolic pressure and +/-dp/dt. In power spectrum analysis of heart rate variability aspect, EA could increase all total variance, very low frequency component, low frequency component and the ratio of low frequency component and high frequency component. When EA with microinjection of N(omega) - Nitro- L-Arginine , a blocker of the formation of nitric oxide, into the ventral periaqueductal gray matter (vPAG), the above effects of EA were abolished or reduced significantly. The results suggest that the depressor effect of EA on stress-induced hypertensive rats might be mediated by nitric oxide in the vPAG due to activation of sympathetic inhibitory system and by attenuated cardiac activities.


Subject(s)
Electroacupuncture , Hypertension/therapy , Nitric Oxide/physiology , Stress, Physiological/complications , Acupuncture Points , Animals , Blood Pressure , Disease Models, Animal , Heart Rate , Hypertension/etiology , Hypertension/physiopathology , Male , Nitric Oxide/biosynthesis , Nitroarginine/pharmacology , Periaqueductal Gray/metabolism , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL
...